Patient Risk Preference to be Used in Clinical Trial Design

A recent project collaboration between RTI Health Solutions, the Medical Device Innovation Consortium (MDIC) and the Michael J. Fox Foundation for Parkinson’s Research (MJFF) represents the first time patient preferences on benefits and risks have been used as an explicit means to set significance levels in a clinical trial design. Learn more here. (Source: RTI International, 10/18/16)

You might also be interested in:

RTI Health Solutions Breaks Down ISPOR/ISPE RWE Guidelines December 10, 2017
ISPOR Announces Nine New Short Courses March 23, 2018
Study: EHRs Could Provide Cost-Effective Means for More… May 25, 2018
Building Trust In Real World Evidence – From Regulators To Patients May 1, 2018
RTI Health Solutions Offers On-Demand Webinar on PROs in… March 27, 2018
eDossier System to Offer hēRo3 Model Integration November 8, 2018
ICCR Investors Seek More Info on Pay Incentives, Long-term Risks December 16, 2017